COMBINATION THERAPY USING HUMAN GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15) INHIBITORS AND IMMUNE CHECKPOINT LOCKERS
CY1125763T1Undetermined Publication Date: 2026-04-17JULIUS MAXIMILIANS UNIV WURZBURG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20221100818T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-04-29
- Filing Date
- 2022-12-29
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2042-12-29
Abstract
The present invention relates to uses of inhibitors of human Growth and Differentiation Factor 15 (GDF-15), and to combined uses of such inhibitors with immune checkpoint blockers, in the treatment of solid cancers.
Need to check novelty before this filing date? Find Prior Art